Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
about
How to tackle tremor - systematic review of the literature and diagnostic work-upMolecular imaging of movement disordersUsefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.Neuroimaging in Parkinson disease: from research setting to clinical practice.Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.A disease-specific metabolic brain network associated with corticobasal degeneration.Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations.Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of ParkinsonismSingle photon-emission computed tomography imaging in early Parkinson's disease.Parkinson's disease--the continuing search for biomarkers.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.Multicenter Semiquantitative Evaluation of (123)I-FP-CIT Brain SPECT.Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms.Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.[Differential diagnostics of Parkinson's disease with nuclear medicine procedures].[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
P2860
Q21129430-66F23992-6978-4FBE-8CBF-4272CDEB6DAEQ28071336-48F159B8-18FB-4754-807B-3BFDDAFB7A49Q28553194-258E4070-81E2-47A3-9F03-8BD88F39F580Q30454798-4D43A2A7-7515-4DB2-9333-64C029FD1C35Q30635471-9B7BCC86-1B13-4264-8091-87CCF3C76C7DQ30829363-0D961EBF-2E5A-4626-91F7-4E2893616DF0Q30851659-A454B944-CDFA-4250-8D6B-EE0AF4861C5DQ30868628-7F572AAA-53B5-43BE-8F7E-124340A991EEQ33879821-7F5C2F0B-100A-4C3E-A5C7-86559F629A92Q34399253-BB86B0CD-156D-42A1-B93B-ABAC4602C2F0Q34554452-5E1E7ECF-1572-45BD-9CAD-046C920FF270Q35726821-75317442-0D4E-4081-8942-2E4791095420Q36331828-FF0891B2-50D0-4954-8A50-CEB42F3C06E2Q36351415-81945BE6-EB85-4230-92A0-D96CDD5A6EB5Q37352055-A8517DA1-3799-43FD-B506-51237D2EB450Q37834648-B47FFBE0-1BD6-45FA-8E7C-2DA9241D995DQ38492560-C618C7DE-B726-42F7-AA53-D727826CC1E9Q38642358-2CD10BA2-2AEE-4CE3-A3C1-2E75909939B1Q38998616-F4B47328-3AEC-4885-A870-120D8199B698Q41000663-30E654A8-0BFC-430E-B1EA-E65D1C4AA96FQ41902470-714B49DA-8CD6-4977-86BA-F827DB442B20Q41969925-AC96AFC9-3841-4867-BCB3-4F05AB963E98Q45709602-0891795E-B454-428F-95BA-C4C2D3BB0573Q48103234-0C95CEE7-D752-49D5-8E55-499D71910CF3Q48111729-6B2EE284-15EB-4D2E-A4EF-5CB1DED07CEBQ48217638-DE6A2765-06B1-43C0-94D2-A21C3BEAA1DAQ48716972-F278B440-E375-4BCA-9D9A-BB996F8F0D09Q50245461-9870693E-7EC6-4FE4-A71A-CF00FB94D922Q50779352-7AB794B0-9558-4CD5-B595-3BB8ADA723D2Q52148846-33852894-8E92-4801-8160-BE5E26EDA894Q53066302-BB389604-CDAE-4F47-BF5F-A48D7F30E497Q53067649-37929625-E3B5-4A0C-B8E1-31B2FC129532
P2860
Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@ast
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@en
type
label
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@ast
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@en
prefLabel
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@ast
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@en
P2093
P2860
P356
P1433
P1476
Meta-analysis of the literatur ...... ECT in parkinsonian syndromes.
@en
P2093
Alfons G H Kessels
Annemarie M M Vlaar
Marinus J P G van Kroonenburgh
Wim E J Weber
P2860
P2888
P356
10.1186/1471-2377-7-27
P577
2007-09-01T00:00:00Z
P5875
P6179
1023924245